DrugPatentWatch Database Preview

Details for Patent: 7,759,308

Which drugs does patent 7,759,308 protect, and when does it expire?

Patent 7,759,308 protects SIGNIFOR LAR and is included in one NDA.

This patent has thirty-seven patent family members in thirty-three countries.

Summary for Patent: 7,759,308

Title:	Microparticles comprising somatostatin analogues
Abstract:	Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles.
Inventor(s):	Ahlheim; Markus (Staufen, DE), Ausborn; Michael (Lorrach, DE), Lambert; Olivier (Spechbach-le-Haut, FR), Riemenschnitter; Marc (Freiburg, DE)
Assignee:	Novartis AG (Basel, CH)
Application Number:	10/579,186
Patent Claim Types: see list of patent claims	Compound; Composition; Device;

Drugs Protected by US Patent 7,759,308

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Novartis Pharms Corp	SIGNIFOR LAR	pasireotide pamoate	POWDER;INTRAMUSCULAR	203255-001	Dec 15, 2014		RX	Yes	No	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Novartis Pharms Corp	SIGNIFOR LAR	pasireotide pamoate	POWDER;INTRAMUSCULAR	203255-002	Dec 15, 2014		RX	Yes	No	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Novartis Pharms Corp	SIGNIFOR LAR	pasireotide pamoate	POWDER;INTRAMUSCULAR	203255-003	Dec 15, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Foreign Priority and PCT Information for Patent: 7,759,308

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0326602.0	Nov 14, 2003
United Kingdom	0406241.0	Mar 19, 2004

PCT Information
PCT Filed	November 12, 2004	PCT Application Number:	PCT/EP2004/012870
PCT Publication Date:	May 26, 2005	PCT Publication Number:	WO2005/046645

Non-Orange Book US Patents Family Members for Patent 7,759,308

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
8,188,037	Microparticles comprising somatostatin analogues	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Family Members for US Patent 7,759,308

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	047310	➤ Sign Up
Austria	455537	➤ Sign Up
Australia	2004289055	➤ Sign Up
Brazil	PI0416227	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 7,759,308

Foreign Priority and PCT Information for Patent: 7,759,308

For more information try a trial or see the plans and pricing